| 摘要 |
The present invention relates to new compounds of formula (I) wherein R<1>, R<2>, R<3>, R<4>, R<5 >and A are defined as in formula (I), a process for their preparation and new intermediate prepared therein, pharmaceutical compositions containing said therapeutically active compounds and to the use of said active compounds in therapy, especially in the treatment of c-Jun N-terminal kinase (JNK) mediated conditions in mammals, particularly Alzheimer's Disease.
|
